These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 32954523)
21. Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis. Chen M; Quan C; Diao L; Xue F; Xue K; Wang B; Li X; Zhu X; Zheng J; Cao H Br J Dermatol; 2018 Dec; 179(6):1334-1341. PubMed ID: 30101523 [TBL] [Abstract][Full Text] [Related]
23. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674 [TBL] [Abstract][Full Text] [Related]
24. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. López de Padilla CM; Vallejo AN; McNallan KT; Vehe R; Smith SA; Dietz AB; Vuk-Pavlovic S; Reed AM Arthritis Rheum; 2007 May; 56(5):1658-68. PubMed ID: 17469160 [TBL] [Abstract][Full Text] [Related]
25. Identification of Similarities Between Skin Lesions in Patients With Antisynthetase Syndrome and Skin Lesions in Patients With Dermatomyositis by Highly Multiplexed Imaging Mass Cytometry. Patel J; Ravishankar A; Maddukuri S; Vazquez T; Grinnell M; Werth VP Arthritis Rheumatol; 2022 May; 74(5):882-891. PubMed ID: 34905301 [TBL] [Abstract][Full Text] [Related]
26. Expression of MxA protein in inflammatory dermatoses. Fäh J; Pavlovic J; Burg G J Histochem Cytochem; 1995 Jan; 43(1):47-52. PubMed ID: 7822763 [TBL] [Abstract][Full Text] [Related]
27. [A case of dermatomyositis positive for anti-nuclear matrix protein 2 antibody without dermatologic symptoms]. Takeuchi E; Hirozawa D; Okiyama N; Inoue M; Nishino I; Sugai F Rinsho Shinkeigaku; 2021 Apr; 61(4):258-261. PubMed ID: 33762494 [TBL] [Abstract][Full Text] [Related]
28. Sarcoplasmic Myxovirus Resistance Protein A: A Study of Expression in Idiopathic Inflammatory Myopathy. Waisayarat J; Wongsuwan P; Tuntiseranee K; Waisayarat P; Dejthevaporn C; Khongkhatithum C; Soponkanaporn S J Inflamm Res; 2023; 16():5417-5426. PubMed ID: 38026261 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis. Fattahi M; Rezaei N; Nematalahi FS; Shaygannejad V; Fouladi S; Karimi L; Fathi F; Dehghani L; Mirmosayyeb O; Eskandari N Mult Scler Relat Disord; 2019 Oct; 35():241-245. PubMed ID: 31421628 [TBL] [Abstract][Full Text] [Related]
31. Immunophenotyping of dendritic cells in lesional, perilesional and distant skin of chronic plaque psoriasis. Alshenawy HA; Hasby EA Cell Immunol; 2011; 269(2):115-9. PubMed ID: 21470599 [TBL] [Abstract][Full Text] [Related]
32. Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases. Wong D; Kea B; Pesich R; Higgs BW; Zhu W; Brown P; Yao Y; Fiorentino D PLoS One; 2012; 7(1):e29161. PubMed ID: 22235269 [TBL] [Abstract][Full Text] [Related]
33. Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies. Inoue M; Tanboon J; Hirakawa S; Komaki H; Fukushima T; Awano H; Tajima T; Yamazaki K; Hayashi R; Mori T; Shibuya K; Yamanoi T; Yoshimura H; Ogawa T; Katayama A; Sugai F; Nakayama Y; Yamaguchi S; Hayashi S; Noguchi S; Tachimori H; Okiyama N; Fujimoto M; Nishino I JAMA Neurol; 2020 Jul; 77(7):872-877. PubMed ID: 32310254 [TBL] [Abstract][Full Text] [Related]
34. Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of Lenabasum Maddukuri S; Patel J; Diaz A; Chen KL; Wysocka M; Bax C; Li Y; Ravishankar A; Grinnell M; Zeidi M; Reddy N; Concha JSS; Bashir MM; Okawa J; White B; Werth VP Arthritis Res Ther; 2022 Jan; 24(1):12. PubMed ID: 34983619 [TBL] [Abstract][Full Text] [Related]
35. Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling. Somani AK; Swick AR; Cooper KD; McCormick TS Arch Dermatol; 2008 Oct; 144(10):1341-9. PubMed ID: 18936398 [TBL] [Abstract][Full Text] [Related]
36. Inverse Relation between MxA Gene Expression and Age in Multiple Sclerosis Patients Reveals a Gender Difference in Response to Interferon Therapy. Taheri M; Mirinezhad M; Omrani MD; Sajjadi E; Inoko H; Sayad A Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):21-27. PubMed ID: 28417621 [TBL] [Abstract][Full Text] [Related]
37. A Study Based on the Correlation Between Slit2/Robo1 Signaling Pathway Proteins and Polymyositis/Dermatomyositis. Chai KX; Chen YQ; Kong LS; Fan PL; Yuan X; Yang J Curr Mol Med; 2020; 20(9):717-722. PubMed ID: 32213157 [TBL] [Abstract][Full Text] [Related]
38. Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis. Duchesne M; Leonard-Louis S; Landon-Cardinal O; Anquetil C; Mariampillai K; Monzani Q; Benveniste O; Allenbach Y Brain Pathol; 2020 Sep; 30(5):867-876. PubMed ID: 32323412 [TBL] [Abstract][Full Text] [Related]
39. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome. Maria NI; Brkic Z; Waris M; van Helden-Meeuwsen CG; Heezen K; van de Merwe JP; van Daele PL; Dalm VA; Drexhage HA; Versnel MA Ann Rheum Dis; 2014 Jun; 73(6):1052-9. PubMed ID: 23831963 [TBL] [Abstract][Full Text] [Related]
40. From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies. Hou C; Durrleman C; Periou B; Barnerias C; Bodemer C; Desguerre I; Quartier P; Melki I; Rice GI; Rodero MP; Charuel JL; Relaix F; Bader-Meunier B; Authier F; Gitiaux C Arthritis Rheumatol; 2021 Jun; 73(6):1044-1052. PubMed ID: 33314705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]